Mereo BioPharma Group plc Net Asset Quality Index
Mereo BioPharma Group plc net asset quality index. Mereo BioPharma Group plc (MAH0) has a Net Asset Quality Index of 89.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €45.92 Million minus total liabilities of €5.00 Million yields net assets of €40.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. See MAH0 total equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Mereo BioPharma Group plc (2016–2025)
Net asset quality index of Mereo BioPharma Group plc from 2016 to 2025. This chart shows how Mereo BioPharma Group plc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 89.1%, representing net assets of €40.92 Million against total assets of €45.92 Million EUR. Check MAH0 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Mereo BioPharma Group plc Net Asset Quality Index by Year (2016–2025)
Mereo BioPharma Group plc net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Mereo BioPharma Group plc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Mereo BioPharma Group plc market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.1% | €40.92 Million | €45.92 Million | €5.00 Million | ▲ +9.3 pp |
| 2024 | 79.8% | €60.97 Million | €76.39 Million | €15.42 Million | ▲ +3.8 pp |
| 2023 | 76.0% | €50.54 Million | €66.50 Million | €15.96 Million | ▲ +5.8 pp |
| 2022 | 70.2% | €61.87 Million | €88.08 Million | €26.21 Million | ▲ +0.6 pp |
| 2021 | 69.6% | €88.00 Million | €126.42 Million | €38.41 Million | ▲ +93.4 pp |
| 2020 | -23.8% | €-14.97 Million | €62.95 Million | €77.92 Million | ▼ -70.3 pp |
| 2019 | 46.6% | €40.26 Million | €86.45 Million | €46.19 Million | ▼ -2.1 pp |
| 2018 | 48.7% | €32.77 Million | €67.28 Million | €34.51 Million | ▼ -16.1 pp |
| 2017 | 64.9% | €62.48 Million | €96.34 Million | €33.85 Million | ▼ -26.5 pp |
| 2016 | 91.3% | €79.26 Million | €86.76 Million | €7.51 Million | — |